Glassy Mountain Advisors’s CVS Health CVS Stock Holding History

Glassy Mountain Advisors’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-75,026	Closed	-$4.43M	–	61
2024 Q2	$4.43M	Sell	75,026 -477	-0.6%	-$29.8K	1.64%	25
2024 Q1	$6.02M	Sell	75,503 -487	-0.6%	-$37.2K	2.27%	19
2023 Q4	$6M	Buy	75,990 +1,650	+2%	+$117K	2.47%	17
2023 Q3	$5.18M	Sell	74,340 -2,949	-4%	-$209K	2.47%	17
2023 Q2	$5.34M	Buy	+77,289	New	+$5.5M	2.38%	17
2023 Q1	–	Sell	-73,758	Closed	-$6.87M	–	60
2022 Q4	$6.87M	Buy	+73,758	New	+$7.12M	3.78%	6
2022 Q2	$6.71M	Sell	72,472 -208	-0.3%	-$20.3K	4.01%	5
2022 Q1	$7.36M	Buy	72,680 +825	+1%	+$86.7K	3.78%	7
2021 Q4	$7.41M	Buy	+71,855	New	+$6.64M	3.83%	9

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Glassy Mountain Advisors's CVS Position: Q3 2024 in Review

Glassy Mountain Advisors sold out of CVS Health (CVS) in Q3 2024, closing a stake of 75,026 shares — an estimated $4.43M sold.

Glassy Mountain Advisors first reported a position in CVS in Q4 2021 and held it in 9 quarters. The position peaked at $7.41M in Q4 2021. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

Glassy Mountain Advisors reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
Glassy Mountain Advisors sold 75,026 CVS Health shares in Q3 2024, an estimated $4.43M.
Glassy Mountain Advisors first reported a position in CVS Health in Q4 2021 and held it in 9 quarters.
Glassy Mountain Advisors's CVS Health position peaked at $7.41M in Q4 2021.
1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Glassy Mountain Advisors's 13F filing for Q3 2024, filed 29 Oct 2024.